Skip to main content
Top
Published in: Sleep and Breathing 4/2015

Open Access 01-12-2015 | Original Article

Frequent sputum production is associated with disturbed night’s rest and impaired sleep quality in patients with COPD

Authors: J. E. Hartman, J. Prinzen, R. C. van Lummel, N. H. T. ten Hacken

Published in: Sleep and Breathing | Issue 4/2015

Login to get access

Abstract

Purpose

In this study, we measured night’s rest parameters measured with an accelerometer and sleep quality in mild to very severe patients with COPD. Furthermore, our aim was to investigate the association between night’s rest parameters and clinical variables and the association between sleep quality and quality of life or health status.

Methods

Mild to very severe COPD patients were recruited from general practitioners and outpatient clinics of general hospitals to participate in a cross-sectional study on physical activity in patients with COPD. A total of 103 patients (mean age 65 years, 67 % male) wore the accelerometer during night’s rest for at least four nights and were included in the analyses.

Results

No significant associations were found between objectively measured body movements during night’s rest or subjective sleep quality and lung function, dyspnoea severity, body composition and physical activity during the day. Patients with frequent sputum production during the day had a higher number of sitting transitions during the night (5.3 vs 4.3 sitting transitions) and more frequently got out of bed compared to patients who hardly ever produced sputum during the day (1.0 vs 0.8 times per night). Furthermore, these patients also reported worse sleep quality (Pittsburgh sleep quality index (PSQI) score 4 vs 3).

Conclusions

Our results indicate that objectively measured body movements during night’s rest like body postures and transitions are not related to sleep quality in patients with COPD. We did find an association between frequent sputum production and disturbances during night’s rest and sleep quality. Future studies should investigate whether the treatment of mucus hypersecretion leads to improved night’s rest.
Literature
1.
go back to reference Agusti A, Hedner J, Marin JM, Barbe F, Cazzola M, Rennard S (2011) Night-time symptoms: a forgotten dimension of COPD. Eur Respir Rev 20:183–194CrossRefPubMed Agusti A, Hedner J, Marin JM, Barbe F, Cazzola M, Rennard S (2011) Night-time symptoms: a forgotten dimension of COPD. Eur Respir Rev 20:183–194CrossRefPubMed
2.
go back to reference Bellia V, Catalano F, Scichilone N, Incalzi RA, Spatafora M, Vergani C, Rengo F (2003) Sleep disorders in the elderly with and without chronic airflow obstruction: the SARA study. Sleep 26:318–323PubMed Bellia V, Catalano F, Scichilone N, Incalzi RA, Spatafora M, Vergani C, Rengo F (2003) Sleep disorders in the elderly with and without chronic airflow obstruction: the SARA study. Sleep 26:318–323PubMed
3.
go back to reference Nunes DM, de Bruin VM, Louzada FM, Peixoto CA, Cavalcante AG, Castro-Silva C, de Bruin PF (2013) Actigraphic assessment of sleep in chronic obstructive pulmonary disease. Sleep Breath 17:125–132CrossRefPubMed Nunes DM, de Bruin VM, Louzada FM, Peixoto CA, Cavalcante AG, Castro-Silva C, de Bruin PF (2013) Actigraphic assessment of sleep in chronic obstructive pulmonary disease. Sleep Breath 17:125–132CrossRefPubMed
4.
go back to reference Valipour A, Lavie P, Lothaller H, Mikulic I, Burghuber OC (2011) Sleep profile and symptoms of sleep disorders in patients with stable mild to moderate chronic obstructive pulmonary disease. Sleep Med 12:367–372CrossRefPubMed Valipour A, Lavie P, Lothaller H, Mikulic I, Burghuber OC (2011) Sleep profile and symptoms of sleep disorders in patients with stable mild to moderate chronic obstructive pulmonary disease. Sleep Med 12:367–372CrossRefPubMed
5.
go back to reference Scharf SM, Maimon N, Simon-Tuval T, Bernhard-Scharf BJ, Reuveni H, Tarasiuk A (2010) Sleep quality predicts quality of life in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulm Dis 6:1–12CrossRef Scharf SM, Maimon N, Simon-Tuval T, Bernhard-Scharf BJ, Reuveni H, Tarasiuk A (2010) Sleep quality predicts quality of life in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulm Dis 6:1–12CrossRef
6.
go back to reference Nunes DM, Mota RM, de Pontes Neto OL, Pereira ED, de Bruin VM, de Bruin PF (2009) Impaired sleep reduces quality of life in chronic obstructive pulmonary disease. Lung 187:159–163CrossRefPubMed Nunes DM, Mota RM, de Pontes Neto OL, Pereira ED, de Bruin VM, de Bruin PF (2009) Impaired sleep reduces quality of life in chronic obstructive pulmonary disease. Lung 187:159–163CrossRefPubMed
7.
go back to reference Soler X, Diaz-Piedra C, Ries AL (2013) Pulmonary rehabilitation improves sleep quality in chronic lung disease. COPD 10:156–163CrossRefPubMed Soler X, Diaz-Piedra C, Ries AL (2013) Pulmonary rehabilitation improves sleep quality in chronic lung disease. COPD 10:156–163CrossRefPubMed
8.
go back to reference Montgomery P, Dennis J (2002) Physical exercise for sleep problems in adults aged 60+. Cochrane Database Syst Rev CD003404 Montgomery P, Dennis J (2002) Physical exercise for sleep problems in adults aged 60+. Cochrane Database Syst Rev CD003404
9.
go back to reference Hartman JE, Boezen HM, de Greef MH, Ten Hacken NH (2013) Physical and psychosocial factors associated with physical activity in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil 94:2396–2402CrossRefPubMed Hartman JE, Boezen HM, de Greef MH, Ten Hacken NH (2013) Physical and psychosocial factors associated with physical activity in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil 94:2396–2402CrossRefPubMed
10.
go back to reference Hartman JE, ten Hacken NH, Boezen HM, de Greef MH (2013) Self-efficacy for physical activity and insight into its benefits are modifiable factors associated with physical activity in people with COPD: a mixed-methods study. J Physiother 59:117–124CrossRefPubMed Hartman JE, ten Hacken NH, Boezen HM, de Greef MH (2013) Self-efficacy for physical activity and insight into its benefits are modifiable factors associated with physical activity in people with COPD: a mixed-methods study. J Physiother 59:117–124CrossRefPubMed
11.
go back to reference Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, Stockley RA, Sin DD, Rodriguez-Roisin R (2012) Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease, GOLD executive summary. Am J Respir Crit Care Med 187:347–365CrossRefPubMed Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, Stockley RA, Sin DD, Rodriguez-Roisin R (2012) Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease, GOLD executive summary. Am J Respir Crit Care Med 187:347–365CrossRefPubMed
12.
go back to reference Van Remoortel H, Raste Y, Louvaris Z, Giavedoni S, Burtin C, Langer D, Wilson F, Rabinovich R, Vogiatzis I, Hopkinson NS, Troosters T, on behalf of PROactive consortium (2012) Validity of six activity monitors in chronic obstructive pulmonary disease: a comparison with indirect calorimetry. PLoS One 7:e39198PubMedCentralCrossRefPubMed Van Remoortel H, Raste Y, Louvaris Z, Giavedoni S, Burtin C, Langer D, Wilson F, Rabinovich R, Vogiatzis I, Hopkinson NS, Troosters T, on behalf of PROactive consortium (2012) Validity of six activity monitors in chronic obstructive pulmonary disease: a comparison with indirect calorimetry. PLoS One 7:e39198PubMedCentralCrossRefPubMed
13.
go back to reference Rabinovich RA, Louvaris Z, Raste Y, Langer D, Remoortel HV, Giavedoni S, Burtin C, Regueiro EM, Vogiatzis I, Hopkinson NS, Polkey MI, Wilson FJ, Macnee W, Westerterp KR, Troosters T, on behalf of the PROactive consortium (2013) Validity of physical activity monitors during daily life in patients with COPD. Eur Respir J 42:1205–1215CrossRefPubMed Rabinovich RA, Louvaris Z, Raste Y, Langer D, Remoortel HV, Giavedoni S, Burtin C, Regueiro EM, Vogiatzis I, Hopkinson NS, Polkey MI, Wilson FJ, Macnee W, Westerterp KR, Troosters T, on behalf of the PROactive consortium (2013) Validity of physical activity monitors during daily life in patients with COPD. Eur Respir J 42:1205–1215CrossRefPubMed
14.
go back to reference Bossenbroek L, Kosse N, Ten Hacken N, Gordijn M, Van der Hoeven J, De Greef M (2010) Validation of the DynaPort MiniMod during sleep: a pilot study. Percept Mot Skills 111:936–946CrossRefPubMed Bossenbroek L, Kosse N, Ten Hacken N, Gordijn M, Van der Hoeven J, De Greef M (2010) Validation of the DynaPort MiniMod during sleep: a pilot study. Percept Mot Skills 111:936–946CrossRefPubMed
15.
go back to reference Buysse DJ, Reynolds CF III, Monk TH, Berman SR, Kupfer DJ (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28:193–213CrossRefPubMed Buysse DJ, Reynolds CF III, Monk TH, Berman SR, Kupfer DJ (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28:193–213CrossRefPubMed
16.
go back to reference Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J, ATS/ERS Task Force (2005) Standardisation of spirometry. Eur Respir J 26:319–338CrossRefPubMed Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J, ATS/ERS Task Force (2005) Standardisation of spirometry. Eur Respir J 26:319–338CrossRefPubMed
17.
go back to reference Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, Casaburi R, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson D, Macintyre N, McKay R, Miller MR, Navajas D, Pellegrino R, Viegi G (2005) Standardisation of the measurement of lung volumes. Eur Respir J 26:511–522CrossRefPubMed Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, Casaburi R, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson D, Macintyre N, McKay R, Miller MR, Navajas D, Pellegrino R, Viegi G (2005) Standardisation of the measurement of lung volumes. Eur Respir J 26:511–522CrossRefPubMed
18.
go back to reference Steiner MC, Barton RL, Singh SJ, Morgan MD (2002) Bedside methods versus dual energy X-ray absorptiometry for body composition measurement in COPD. Eur Respir J 19:626–631CrossRefPubMed Steiner MC, Barton RL, Singh SJ, Morgan MD (2002) Bedside methods versus dual energy X-ray absorptiometry for body composition measurement in COPD. Eur Respir J 19:626–631CrossRefPubMed
19.
go back to reference Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA (1999) Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 54:581–586PubMedCentralCrossRefPubMed Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA (1999) Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 54:581–586PubMedCentralCrossRefPubMed
20.
go back to reference van der Molen T, Willemse BW, Schokker S, ten Hacken NH, Postma DS, Juniper EF (2003) Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes 1:13PubMedCentralCrossRefPubMed van der Molen T, Willemse BW, Schokker S, ten Hacken NH, Postma DS, Juniper EF (2003) Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes 1:13PubMedCentralCrossRefPubMed
21.
go back to reference Jones PW, Quirk FH, Baveystock CM (1991) The St. George’s Respiratory Questionnaire. Respir Med Suppl B:25–31, discussion 33–7CrossRef Jones PW, Quirk FH, Baveystock CM (1991) The St. George’s Respiratory Questionnaire. Respir Med Suppl B:25–31, discussion 33–7CrossRef
22.
go back to reference Aaronson NK, Muller M, Cohen PD, Essink-Bot ML, Fekkes M, Sanderman R, Sprangers MA, te Velde A, Verrips E (1998) Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol 51:1055–1068CrossRefPubMed Aaronson NK, Muller M, Cohen PD, Essink-Bot ML, Fekkes M, Sanderman R, Sprangers MA, te Velde A, Verrips E (1998) Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol 51:1055–1068CrossRefPubMed
23.
go back to reference Trost SG, McIver KL, Pate RR (2005) Conducting accelerometer-based activity assessments in field-based research. Med Sci Sports Exerc 37:S531–43CrossRefPubMed Trost SG, McIver KL, Pate RR (2005) Conducting accelerometer-based activity assessments in field-based research. Med Sci Sports Exerc 37:S531–43CrossRefPubMed
24.
go back to reference Watz H, Waschki B, Meyer T, Magnussen H (2009) Physical activity in patients with COPD. Eur Respir J 33:262–272CrossRefPubMed Watz H, Waschki B, Meyer T, Magnussen H (2009) Physical activity in patients with COPD. Eur Respir J 33:262–272CrossRefPubMed
25.
go back to reference Willemse BW, Postma DS, Timens W, ten Hacken NH (2004) The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation. Eur Respir J 23:464–476CrossRefPubMed Willemse BW, Postma DS, Timens W, ten Hacken NH (2004) The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation. Eur Respir J 23:464–476CrossRefPubMed
26.
go back to reference Kim V, Criner GJ (2013) Chronic bronchitis and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 187:228–237CrossRefPubMed Kim V, Criner GJ (2013) Chronic bronchitis and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 187:228–237CrossRefPubMed
27.
go back to reference Shackell BS, Jones RC, Harding G, Pearse S, Campbell J (2007) ‘Am I going to see the next morning?’ A qualitative study of patients’ perspectives of sleep in COPD. Prim Care Respir J 16:378–383CrossRefPubMed Shackell BS, Jones RC, Harding G, Pearse S, Campbell J (2007) ‘Am I going to see the next morning?’ A qualitative study of patients’ perspectives of sleep in COPD. Prim Care Respir J 16:378–383CrossRefPubMed
Metadata
Title
Frequent sputum production is associated with disturbed night’s rest and impaired sleep quality in patients with COPD
Authors
J. E. Hartman
J. Prinzen
R. C. van Lummel
N. H. T. ten Hacken
Publication date
01-12-2015
Publisher
Springer Berlin Heidelberg
Published in
Sleep and Breathing / Issue 4/2015
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-014-1111-9

Other articles of this Issue 4/2015

Sleep and Breathing 4/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine